| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, Florida 33101 [M. K., K. L. C.]; and Mount Sinai Medical Center, Miami Beach, Florida 33140 [L. Y.]
Sialomucin complex (SMC) is a large heterodimeric glycoprotein complex composed of a mucin subunit ascites sialoglycoprotein-1 and a transmembrane subunit ascites sialoglycoprotein-2. It is a rat homologue of human mucin gene MUC4 and is abundantly expressed on the cell surface of highly metastatic ascites 13762 rat mammary adenocarcinoma cells. Because of their extended and rigid structures, mucin-type glycoproteins are suggested to have suppressing effects on cell-cell and cell-matrix interactions. During the metastatic process, these effects presumably cause tumor cell detachment from the primary tumor mass and facilitate escape of the tumor cells from immunosurveillance. Analyses of human breast cancer cells in solid tumors and tumor effusions showed that the more aggressive cells in effusions are stained with polyclonal antibodies against SMC more frequently than cells in solid tumors, suggesting a role for MUC4/SMC in tumor progression and metastasis. Previously, we generated recombinant cDNAs for SMC that vary in the number of mucin repeats to study the putative functions of SMC in tumor metastasis. These cDNAs were transfected into human cancer cell lines and tested for the effect of the expression of this gene. Here, using a tetracycline-responsive inducible expression system, we demonstrate that overexpression of SMC masks the surface antigens on target tumor cells and effectively suppresses tumor cell killing by cytotoxic lymphocytes. This effect results from the ability of SMC to block killer cell binding to the tumor cells and is dependent on both overexpression of the mucin and the number of mucin repeats in the expressed SMC. These results provide an explanation for the proposed role of SMC/MUC4 in tumor progression.
This article has been cited by other articles:
|
|
 |
|
  H. C. Workman, C. Sweeney, and K. L. Carraway III The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms Cancer Res., April 1, 2009; 69(7): 2845 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chaturvedi, A. P. Singh, and S. K. Batra Structure, evolution, and biology of the MUC4 mucin FASEB J, April 1, 2008; 22(4): 966 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pino, V. P. Ramsauer, P. Salas, C. A. C. Carraway, and K. L. Carraway Membrane Mucin Muc4 Induces Density-dependent Changes in ERK Activation in Mammary Epithelial and Tumor Cells: ROLE IN REVERSAL OF CONTACT INHIBITION J. Biol. Chem., September 29, 2006; 281(39): 29411 - 29420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Funes, J. K. Miller, C. Lai, K. L. Carraway III, and C. Sweeney The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3 J. Biol. Chem., July 14, 2006; 281(28): 19310 - 19319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Ramsauer, V. Pino, A. Farooq, C. A. Carothers Carraway, P. J.I. Salas, and K. L. Carraway Muc4-ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2 Mol. Biol. Cell, July 1, 2006; 17(7): 2931 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mesri, G. Smithson, A. Ghatpande, A. Chapoval, S. Shenoy, F. Boldog, C. Hackett, C. E. Pena, C. Burgess, A. Bendele, et al. Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins Int. Immunol., March 1, 2006; 18(3): 473 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Saitou, M Goto, M Horinouchi, S Tamada, K Nagata, T Hamada, M Osako, S Takao, S K Batra, T Aikou, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas J. Clin. Pathol., August 1, 2005; 58(8): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nagy, E. Friedlander, M. Tanner, A. I. Kapanen, K. L. Carraway, J. Isola, and T. M. Jovin Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line Cancer Res., January 15, 2005; 65(2): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D A Bax, J Haringsma, A W C Einerhand, H van Dekken, P Blok, P D Siersema, E J Kuipers, and J G Kusters MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio J. Clin. Pathol., December 1, 2004; 57(12): 1267 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Singh, N. Moniaux, S. C. Chauhan, J. L. Meza, and S. K. Batra Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis Cancer Res., January 15, 2004; 64(2): 622 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perez, R. Barco, I. Fernandez, S. A. Price-Schiavi, and K. L. Carraway PEA3 Transactivates the Muc4/Sialomucin Complex Promoter in Mammary Epithelial and Tumor Cells J. Biol. Chem., September 19, 2003; 278(38): 36942 - 36952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Ramsauer, C. A. C. Carraway, P. J. I. Salas, and K. L. Carraway Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells J. Biol. Chem., August 8, 2003; 278(32): 30142 - 30147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Soto, S. A. Price-Schiavi, and K. L. Carraway SMAD2 and SMAD7 Involvement in the Post-translational Regulation of Muc4 via the Transforming Growth Factor-{beta} and Interferon-{gamma} Pathways in Rat Mammary Epithelial Cells J. Biol. Chem., May 23, 2003; 278(22): 20338 - 20344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Fischer, J. G. Cuellar, M. L. Diehl, A. M. deFreytas, J. Zhang, K. L. Carraway, and J. A. Voynow Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L671 - L679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Leikauf, M. T. Borchers, D. R. Prows, and L. G. Simpson Mucin Apoprotein Expression in COPD* Chest, May 1, 2002; 121 (2009): 166S - 182S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Arango, P. Li, M. Komatsu, C. Montes, C. A. C. Carraway, and K. L. Carraway Production and Localization of Muc4/Sialomucin Complex and Its Receptor Tyrosine Kinase ErbB2 in the Rat Lacrimal Gland Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2749 - 2756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Loukas, M. Hintz, D. Linder, N. P. Mullin, J. Parkinson, K. K. A. Tetteh, and R. M. Maizels A Family of Secreted Mucins from the Parasitic Nematode Toxocara canis Bears Diverse Mucin Domains but Shares Similar Flanking Six-cysteine Repeat Motifs J. Biol. Chem., December 8, 2000; 275(50): 39600 - 39607. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
